Ro 48–8071, an OSC inhibitor, shows anti-tumor effect (Maione et al., 2015), and more importantly, it synergizes with 5-fluorouracil, thus eliciting an enhanced anti-tumor outcome. Here, LSS is linked to neoplasm.